Silhouette represents a new class of synthetic biomaterials that aims to provide optimized intraoperative handling and biologic responsiveness at the defect site. The bone graft comprises a clinically proven bi-phasic mineral component suspended within a woven network of type I collagen fibers. It is tailored to support bone bonding and sustained remodeling during healing process.
More articles on devices:
TissueGen to expand spinal cord injury repair program — 5 key updates
K2M’s MESA 2 Deformity Spinal System receives FDA 510(k) clearance
Dr. John Peloza performs 1st U.S. surgery using FLXfit 3D expandable interbody cage
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
